4.4 Article

Pleiotropic Role of HSF1 in Neoplastic Transformation

Journal

CURRENT CANCER DRUG TARGETS
Volume 14, Issue 2, Pages 144-155

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568009614666140122155942

Keywords

Cancer; drug resistance; genomic instability; HSF1 inhibitors; HSPs; metastasis; p53 signaling

Categories

Funding

  1. Polish Ministry of Science and Higher Education [N N401 031837, N N301 002439]
  2. European Community [UDA - POKL-04.01.01-00-014/10-00]

Ask authors/readers for more resources

HSF1 (Heat Shock transcription Factor 1) is the main transcription factor activated in response to proteotoxic stress. Once activated, it induces an expression of heat shock proteins (HSPs) which enables cells to survive in suboptimal conditions. HSF1 could be also activated by altered kinase signaling characteristic for cancer cells, which is a probable reason for its high activity found in a broad range of tumors. There is rapidly growing evidence that HSF1 supports tumor initiation and growth, as well as metastasis and angiogenesis. It also modulates the sensitivity of cancer cells to therapy. Functions of HSF1 in cancer are connected with HSPs' activity, which generally protects cells from apoptosis, but also are independent of its classical targets. HSF1-dependent regulation of non-HSPs genes plays a role in cell cycle progression, glucose metabolism, autophagy and drug efflux. HSF1 affects the key cell-survival and regulatory pathways, including p53, RAS/MAPK, cAMP/PKA, mTOR and insulin signaling. Although the exact mechanism of HSF1 action is still somewhat obscure, HSF1 is becoming an attractive target in anticancer therapies, whose inhibition could enhance the effects of other treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available